Compound Detail
CHEMBL2088013
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL2088013 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RLACRPKMRNEAIU-UHFFFAOYSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
20
Publications
0
Known Names
Molecular Properties
326.6
MW (Da)
4.06
ALogP
2
HBA
2
HBD
49.3
PSA (Ų)
0.87
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 5.5
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 5.5 | 5.5 | 3140.0 | 1 |
| Leishmania donovani CHEMBL367 | IC50 | 5.42 | 5.42 | 3830.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 4.8 | 4.8 | 15720.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| NON-PROTEIN TARGET | IC50 | = | 3140.0 | nM | 5.5 | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability a... | 28126437 |
| Leishmania donovani | IC50 | = | 3830.0 | nM | 5.42 | Antileishmanial activity against Leishmania donovani amastigotes infected in J77... | 36565533 |
| HepG2 | IC50 | = | 15720.0 | nM | 4.8 | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability a... | 24953953 |
Literature References
Data from ChEMBL 36 via Core Engine